The cell therapy field is experiencing rapid growth with several treatments receiving recent regulatory approval and several therapies currently in clinical testing. Thermo Fisher Scientific has a line of Gibco™ CTS™ cell therapy devices developed to function as either a stand-alone system or integrated into a workflow that can help with the maintenance of critical quality attributes during manufacturing scale-up.

As a part of this workflow, the Gibco™ CTS™ DynaCellect™ Magnetic Separation System and single-use kits have been designed for scalable and robust cell processing with the CTS Dynabeads™ platform. The instrument utilizes an integrated magnet-rocker and a fluidics panel for target cell separation and subsequent bead removal in a closed system.